Innovative Approach Shows Promise Against Synovial Sarcoma Using Protein-Blocking Drugs

The Synovial Sarcoma Foundation is dedicated to supporting cutting-edge research that advances treatment options for this rare and aggressive cancer.…

New Market Insights Highlight Growth in Synovial Sarcoma Treatments

The Synovial Sarcoma Foundation is committed to staying informed on the latest research and developments in this rare and aggressive…

Tumor Board Continues to Grow with New Members to Advance Breakthrough Treatments for Synovial Sarcoma Patients

We are proud to share that the Tumor Board now includes 42 participating institutions, strengthening our collective expertise and reach.…

Synovial Sarcoma Foundation Celebrates Groundbreaking Achievement by Rachel Dr. Hurly

The Synovial Sarcoma Foundation is proud to announce a significant milestone in pediatric cancer research: Dr. Rachel Hurly, a dedicated…

Callan Spence: Survivor. Driver. Relentless Advocate.

Callan Spence isn’t waiting for progress—he’s chasing it down at full speed. At 20 years old, Callan is already a…

Inaugural Synovial Sarcoma Conference

On March 1, CHOP, in collaboration with Penn Medicine and the Synovial Sarcoma Foundation, hosted the first-ever national virtual conference…

The Synovial Sarcoma Foundation Surpasses $2 Million in Research Funding

Thanks to the generosity of donors and supporters, the Fund has now raised over $2 million, accelerating research initiatives at…

First-Ever Synovial Sarcoma Conference to Bring Together Patients, Researchers, and Experts in a Landmark Event

PHILADELPHIA, PA, UNITED STATES, February 20, 2025 — The Synovial Sarcoma Foundation is proud to announce that Children’s Hospital of Philadelphia…